HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) Stock Fundamental Analysis

TSX-V:HIVE • CA4339211035

3.03 CAD
+0.11 (+3.77%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

HIVE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 69 industry peers in the Software industry. The financial health of HIVE is average, but there are quite some concerns on its profitability. HIVE is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year HIVE was profitable.
  • HIVE had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: HIVE reported negative net income in multiple years.
  • HIVE had a positive operating cash flow in each of the past 5 years.
HIVE.CA Yearly Net Income VS EBIT VS OCF VS FCFHIVE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

1.2 Ratios

  • HIVE's Return On Assets of 2.98% is fine compared to the rest of the industry. HIVE outperforms 68.12% of its industry peers.
  • Looking at the Return On Equity, with a value of 3.30%, HIVE is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
Industry RankSector Rank
ROA 2.98%
ROE 3.3%
ROIC N/A
ROA(3y)-37.49%
ROA(5y)-16.27%
ROE(3y)-49.77%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
HIVE.CA Yearly ROA, ROE, ROICHIVE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

1.3 Margins

  • HIVE has a better Profit Margin (10.67%) than 82.61% of its industry peers.
  • HIVE does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 10.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIVE.CA Yearly Profit, Operating, Gross MarginsHIVE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • HIVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, HIVE has more shares outstanding
  • HIVE has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, HIVE has an improved debt to assets ratio.
HIVE.CA Yearly Shares OutstandingHIVE.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
HIVE.CA Yearly Total Debt VS Total AssetsHIVE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 4.49 indicates that HIVE is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.49, HIVE is doing good in the industry, outperforming 78.26% of the companies in the same industry.
  • A Debt/Equity ratio of 0.03 indicates that HIVE is not too dependend on debt financing.
  • HIVE has a Debt to Equity ratio of 0.03. This is in the better half of the industry: HIVE outperforms 72.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 4.49
ROIC/WACCN/A
WACC10.28%
HIVE.CA Yearly LT Debt VS Equity VS FCFHIVE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.55 indicates that HIVE has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.55, HIVE is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
  • HIVE has a Quick Ratio of 2.55. This indicates that HIVE is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 2.55, HIVE is doing good in the industry, outperforming 73.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 2.55
HIVE.CA Yearly Current Assets VS Current LiabilitesHIVE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 301.67% over the past year.
  • HIVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 57.09%.
  • Measured over the past years, HIVE shows a very strong growth in Revenue. The Revenue has been growing by 31.59% on average per year.
EPS 1Y (TTM)301.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.09%
Revenue growth 3Y-18.07%
Revenue growth 5Y31.59%
Sales Q2Q%285.26%

3.2 Future

  • The Earnings Per Share is expected to decrease by -154.47% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 70.47% on average over the next years. This is a very strong growth
EPS Next Y-258.82%
EPS Next 2Y92.38%
EPS Next 3Y-154.47%
EPS Next 5YN/A
Revenue Next Year182.4%
Revenue Next 2Y102.05%
Revenue Next 3Y70.47%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HIVE.CA Yearly Revenue VS EstimatesHIVE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
HIVE.CA Yearly EPS VS EstimatesHIVE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.94, the valuation of HIVE can be described as rather expensive.
  • HIVE's Price/Earnings ratio is a bit cheaper when compared to the industry. HIVE is cheaper than 78.26% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of HIVE to the average of the S&P500 Index (27.19), we can say HIVE is valued slightly cheaper.
  • HIVE is valuated quite expensively with a Price/Forward Earnings ratio of 68.81.
  • Based on the Price/Forward Earnings ratio, HIVE is valued a bit cheaper than 62.32% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, HIVE is valued quite expensively.
Industry RankSector Rank
PE 18.94
Fwd PE 68.81
HIVE.CA Price Earnings VS Forward Price EarningsHIVE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • HIVE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HIVE is cheaper than 65.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.27
HIVE.CA Per share dataHIVE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A cheap valuation may be justified as HIVE's earnings are expected to decrease with -154.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y92.38%
EPS Next 3Y-154.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HIVE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIVE DIGITAL TECHNOLOGIES LT

TSX-V:HIVE (2/13/2026, 7:00:00 PM)

3.03

+0.11 (+3.77%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-10
Earnings (Next)06-24
Inst Owners25.21%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap760.29M
Revenue(TTM)193.25M
Net Income(TTM)20.63M
Analysts80
Price Target9.05 (198.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)92.46%
Min EPS beat(2)-84.82%
Max EPS beat(2)269.73%
EPS beat(4)3
Avg EPS beat(4)98.81%
Min EPS beat(4)-84.82%
Max EPS beat(4)269.73%
EPS beat(8)7
Avg EPS beat(8)83.97%
EPS beat(12)8
Avg EPS beat(12)5.52%
EPS beat(16)10
Avg EPS beat(16)-99.68%
Revenue beat(2)2
Avg Revenue beat(2)10.1%
Min Revenue beat(2)3.29%
Max Revenue beat(2)16.9%
Revenue beat(4)3
Avg Revenue beat(4)6.2%
Min Revenue beat(4)-1.52%
Max Revenue beat(4)16.9%
Revenue beat(8)6
Avg Revenue beat(8)6.47%
Revenue beat(12)9
Avg Revenue beat(12)6.95%
Revenue beat(16)12
Avg Revenue beat(16)15.9%
PT rev (1m)0%
PT rev (3m)36.54%
EPS NQ rev (1m)24.32%
EPS NQ rev (3m)-31.26%
EPS NY rev (1m)36.72%
EPS NY rev (3m)-156.25%
Revenue NQ rev (1m)3.66%
Revenue NQ rev (3m)4.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.45%
Valuation
Industry RankSector Rank
PE 18.94
Fwd PE 68.81
P/S 2.89
P/FCF N/A
P/OCF 26.24
P/B 0.89
P/tB 0.89
EV/EBITDA 16.27
EPS(TTM)0.16
EY5.28%
EPS(NY)0.04
Fwd EY1.45%
FCF(TTM)-0.71
FCFYN/A
OCF(TTM)0.12
OCFY3.81%
SpS1.05
BVpS3.39
TBVpS3.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.49
Profitability
Industry RankSector Rank
ROA 2.98%
ROE 3.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.67%
GM N/A
FCFM N/A
ROA(3y)-37.49%
ROA(5y)-16.27%
ROE(3y)-49.77%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.56
Cap/Depr 161.26%
Cap/Sales 79.14%
Interest Coverage N/A
Cash Conversion 75.95%
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 2.55
Altman-Z 4.49
F-Score6
WACC10.28%
ROIC/WACCN/A
Cap/Depr(3y)97.27%
Cap/Depr(5y)157.57%
Cap/Sales(3y)54.64%
Cap/Sales(5y)58.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)301.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y-258.82%
EPS Next 2Y92.38%
EPS Next 3Y-154.47%
EPS Next 5YN/A
Revenue 1Y (TTM)57.09%
Revenue growth 3Y-18.07%
Revenue growth 5Y31.59%
Sales Q2Q%285.26%
Revenue Next Year182.4%
Revenue Next 2Y102.05%
Revenue Next 3Y70.47%
Revenue Next 5YN/A
EBIT growth 1Y-66.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year327.7%
EBIT Next 3Y75.96%
EBIT Next 5YN/A
FCF growth 1Y-521.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.27%
OCF growth 3Y-36.92%
OCF growth 5Y84.91%

HIVE DIGITAL TECHNOLOGIES LT / HIVE.CA FAQ

Can you provide the ChartMill fundamental rating for HIVE DIGITAL TECHNOLOGIES LT?

ChartMill assigns a fundamental rating of 4 / 10 to HIVE.CA.


Can you provide the valuation status for HIVE DIGITAL TECHNOLOGIES LT?

ChartMill assigns a valuation rating of 2 / 10 to HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA). This can be considered as Overvalued.


Can you provide the profitability details for HIVE DIGITAL TECHNOLOGIES LT?

HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) has a profitability rating of 3 / 10.


What is the valuation of HIVE DIGITAL TECHNOLOGIES LT based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) is 18.94 and the Price/Book (PB) ratio is 0.89.


What is the earnings growth outlook for HIVE DIGITAL TECHNOLOGIES LT?

The Earnings per Share (EPS) of HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) is expected to decline by -258.82% in the next year.